Key Takeaways:
- Hawkins Q1 EPS of $1.35 missed the $1.42 consensus estimate.
- Revenue of $315.7M fell short of the $319.7M analyst forecast.
- The specialty chemicals company missed on both top and bottom lines.
뒤로
Hawkins misses Q1 estimates with EPS of $1.35, below $1.42 view
Hawkins Inc. reported Q1 earnings of $1.35 a share, missing the $1.42 consensus estimate, as revenue also fell short of analyst projections.
The company did not provide a management comment with the release. Hawkins, a specialty chemicals and ingredients distributor based in Roseville, Minnesota, operates through three segments: water treatment, health and nutrition, and industrial.
Revenue for the quarter ended June 28 totaled $315.7 million, below the $319.7 million analysts had projected. The 1.3% revenue shortfall and 5.1% EPS miss versus consensus mark a reversal for the company, which had beaten EPS estimates in each of the prior four quarters.
The water treatment segment, Hawkins' largest by revenue, faces ongoing pricing pressure from commodity chemical competitors, which may have contributed to the quarterly shortfall. The health and nutrition segment, which supplies ingredients to food and beverage manufacturers, has seen stable demand but faces input cost volatility. Hawkins' industrial segment serves customers in agriculture and construction end markets.
The miss comes as specialty chemical companies broadly navigate a mixed demand environment. Peer companies such as Ecolab and Chemours have reported varying results, with some benefiting from infrastructure-related spending and others facing headwinds from lower commodity chemical prices and elevated raw material costs.
Hawkins has not yet disclosed guidance for the current quarter. The company's ability to manage input costs and pass through pricing will be key for margins in the coming quarters. Investors will watch the upcoming earnings call for management's assessment of demand trends across its three segments and any updates to the full-year outlook.
This article is for informational purposes only and does not constitute investment advice.
